China has become the first country to approve a brain-computer interface (BCI) device for commercial use, marking a significant leap forward in neurotechnology. The system, developed by Borui Kang Medical Technology (Shanghai), is designed to restore hand movement in paralyzed patients.
Restoring Movement Through Invasive Technology
The approved BCI is an invasive system, meaning electrodes are surgically implanted directly into the brain. This approach—using minimally invasive extradural implantation and wireless connectivity—allows the device to bypass damaged neural pathways. Specifically, it targets individuals with quadriplegia resulting from cervical spinal cord injuries, enabling them to regain hand-grasping ability through a specialized glove.
The regulator’s approval is based on clinical trial data that demonstrated significant improvements in hand function among participants, which translated to a better quality of life. Patients must meet strict eligibility criteria: aged 18 to 60, at least one year post-injury, and stable for six months after initial treatment. They must also retain some upper-arm function but be unable to grasp with their hands.
Strategic Importance and Global Competition
Beijing’s decision to fast-track BCI development highlights its strategic importance within China’s future industrial plans. The technology was recently designated a “future industry” in the country’s latest five-year plan, signaling that the government is prioritizing its advancement.
This move places China in direct competition with U.S.-based startups like Elon Musk’s Neuralink, which are also racing to commercialize BCI technology. Experts estimate that practical public use of BCIs in China could become widespread within three to five years, as products mature and regulatory frameworks adapt.
The approval of this device is a clear sign that China is determined to become a leader in the rapidly evolving field of neurotechnology, with potentially far-reaching implications for medical treatment and human-machine interfaces.
